Femara (Letrozole)
Active Substance: Femara
Description
Femara (Letrozole)
What it is and other names:
Letrozole is a medication that belongs to a class of drugs called aromatase inhibitors. It is sold under the brand name Femara, among others. It works by blocking the enzyme aromatase, which is responsible for converting androgens (male hormones) into estrogens (female hormones).
Primary uses:
-
Breast Cancer: Letrozole is primarily used to treat certain types of breast cancer in postmenopausal women. By lowering estrogen levels, it can slow or stop the growth of hormone receptor-positive breast cancer cells.
-
Infertility and Ovulation Induction: Letrozole is also used off-label as a first-line treatment for ovulation induction in women with polycystic ovary syndrome (PCOS) and other ovulatory issues.
Side Effects and Benefits
Benefits:
-
Effective Breast Cancer Treatment: It has been shown to be effective in reducing the recurrence of breast cancer in postmenopausal women.
-
Ovulation Induction: It can be highly effective at inducing ovulation in women who have difficulty ovulating on their own, often with a higher rate of live births compared to other similar medications.
-
Fewer Side Effects than Some Alternatives: In fertility treatment, it is sometimes used as an alternative to clomiphene (Clomid) because it may have fewer unpleasant side effects.
Side Effects:
Because letrozole lowers estrogen levels, many of its side effects are similar to symptoms of menopause. Common side effects include:
-
Hot flashes and night sweats
-
Joint and muscle pain
-
Fatigue and dizziness
-
Headaches
-
Nausea and/or vomiting
-
Bone thinning (osteoporosis), which can increase the risk of fractures over time.
More serious side effects, though less common, can include:
-
Blood clots
-
Elevated blood pressure and cholesterol
-
Liver problems
-
Allergic reactions
Pros and Cons
Pros:
-
High Efficacy: Letrozole is a very effective medication for its approved uses, particularly in breast cancer treatment and for inducing ovulation.
-
Oral Administration: It is a convenient oral tablet.
-
Fewer Complications: In some cases, it may have a better side effect profile than similar medications.
Cons:
-
Estrogen Depletion: The mechanism of action, which is to significantly lower estrogen levels, is responsible for the many side effects that can impact quality of life.
-
Potential for Off-Label Use Issues: Its use for fertility is off-label, which means it wasn't originally developed for this purpose. While it is widely used and considered safe for this indication, some countries have raised concerns about its use for infertility.
-
Long-Term Bone Health: Long-term use can increase the risk of osteoporosis.
Dosage and Frequency
-
Breast Cancer: The typical recommended dose is 2.5 mg once a day. Treatment often continues for about 5 years, but can be prescribed for a longer or shorter duration depending on the patient's condition.
-
Ovulation Induction: The most common dosage for ovulation induction is 2.5 mg per day, usually taken for 5 days, starting on the 3rd or 5th day of the menstrual cycle. Higher doses of 5 mg or 7.5 mg may also be used.
Pharmacokinetics
-
Half-life: The terminal elimination half-life of letrozole is approximately 2 days (42-48 hours). This means it takes about two days for the body to eliminate half of the drug.
-
Detection Time: Due to its half-life, letrozole can be detectable in the body for a significant period. While a precise detection window can vary based on individual metabolism, dosage, and testing method, it can be detectable for several weeks after the last dose. This is why it is listed as a performance-enhancing drug by anti-doping agencies.
Sterogenic, Progestogenic, and Prolactin Effects
-
Sterogenic Effects: Letrozole is an anti-estrogen. It does not have anabolic or androgenic properties. In men, by blocking aromatase, it prevents the conversion of testosterone into estradiol (a form of estrogen), which can lead to an increase in endogenous testosterone levels.
-
Progestogenic Effects: Letrozole does not have direct progestogenic effects. It is not a progesterone-type hormone.
-
Prolactin Effects: Letrozole is not known to have a direct effect on prolactin levels. However, because it can alter the balance of other hormones, any indirect effects on prolactin would need to be evaluated on a case-by-case basis. High prolactin levels (hyperprolactinemia) can cause infertility, and letrozole is not used to treat this condition directly.
Anabolic Androgenic Ratio
Letrozole is not an anabolic-androgenic steroid. Therefore, it does not have an anabolic-androgenic ratio. Anabolic-androgenic ratio is a measure used to describe the balance of anabolic (muscle-building) effects versus androgenic (masculinizing) effects of a substance. Letrozole's mechanism of action is completely different from that of steroids.
Pharmacological Properties
Half Life
2 days
Active Dose
100%
Detection
10.00 days
Concentration
10 mg/tab
Anabolic/Androgenic Profile
Usage Effectiveness
Activity Profile
Estrogenic
None
Progestanic
None
Water Retention
None
Aromatization
No
Benefits
Dosage Recommendations
Beginner
1-2 mg/week
Intermediate
2-5 mg/week
Advanced
5-10 mg/week
Evidence-based planning resources
Dive deeper into Femara (Letrozole) cycle design, stacking options, and harm-reduction checklists available inside Anabolic Planner.
- Femara (Letrozole) compound database overviewCompare Femara (Letrozole) with other ancillary agents in the structured compound index.
- Femara (Letrozole) stack and cycle templatesReview evidence-based cycle outlines, dose progressions, and PCT pairings that incorporate Femara (Letrozole).
- Harm-reduction guide for Femara (Letrozole)Refresh safety monitoring, lab work, and countermeasure strategies tailored for Femara (Letrozole) protocols.
Peer-reviewed reference material
Validate mechanisms, contraindications, and regulatory guidance for Femara (Letrozole) with trusted clinical databases.
- Femara clinical research on PubMedSearch peer-reviewed human and veterinary studies discussing efficacy, endocrine impact, and contraindications.
- Femara pharmacology via Drug Information PortalReview mechanisms, synonyms, regulatory status, and toxicology summaries from the U.S. National Library of Medicine.
Side Effects
Common
Severe
Safety Information
Liver Toxicity
None
Kidney Toxicity
Low
Cardiovascular Risk
Low
Disclaimer: This information is for educational purposes only. Always consult with a qualified healthcare professional before using any compounds.